ATH 0.00% 0.3¢ alterity therapeutics limited

36 genes related to iron in brain, page-4

  1. 1,345 Posts.
    lightbulb Created with Sketch. 123
    Hi Pivalde,

    Two good reads, thankyou for these.

    As stated below, once we get market approval use, many doors will open for its use. And seeing many more neurodegenerating illnesses identified by iron overload, ATH434 will definately be studied and utilised in so many more treatments.....hoping for a good mid point open study report
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.2¢ $36.94K 11.98M

Buyers (Bids)

No. Vol. Price($)
1 741680 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 152086887 65
View Market Depth
Last trade - 16.10pm 05/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.